I
INNOVO (Atlantic Therapeutics)
The Only Clinically-Proven, Wearable, Home-Based Urinary Incontinence Treatment
About INNOVO (Atlantic Therapeutics)
Recommended by 98% of physicians and 90% of users, INNOVO is the perfect solution for treating stress urinary incontinence.
Safe, effective and FDA-cleared, INNOVO offers the only clinically-proven, wearable and truly non-invasive solution for stress urinary incontinence (SUI). Using unique multipath™ technology, INNOVO targets the weakened pelvic floor muscles, delivering 180 perfect and complete pelvic floor contractions over each 30-minute session.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Galway, Ireland
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 28.3/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Health and Wellness, Neurology, Remote Monitoring, Non-Invasive medical devices and treatments, Spinout, Femtech, Sustainable Development Goals, Tech for Patients, Pelvic Health, Digital Care
- Business model
- Manufacturing
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2023 | $0 | — | Caldera Medical | ↗ |
| LATE VCOther financing | Jan 2022 | $20M | $154M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for INNOVO (Atlantic Therapeutics) is 500 monthly website visits, up 28.2% over the last three months. INNOVO (Atlantic Therapeutics)'s team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Enterprise Ireland
Series A3 investors entered at this stage
EQT Life Sciences
Atlantic Bridge
Andera Partners
Series B and later4 investors entered at this stage
Earlybird Venture Capital
Seroba Life Sciences
HSBC Innovation Banking
Western Development Commission
Other known investors2 additional known investors
Caldera Medical
University College Dublin
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about INNOVO (Atlantic Therapeutics) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See INNOVO (Atlantic Therapeutics)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







